|Please join us on Tuesday, April 30, 2013 at 11:00 a.m. (ET) for a complimentary webinar to discuss the initial implementation of Sections 218 and 219 of the Iran Threat Reduction and Syria Human Rights Act (the “ITRA”). Pamela K. Dayanim will discuss approaches issuers have taken in addressing the new federal securities disclosure requirements and factors companies will need to consider in making future disclosures. Alexandre Lamy will discuss international trade considerations companies need to take into account when making the required disclosures in light of the expanded scope of US sanctions targeting Iran.
About ITRA Sections 218 and 219
US companies and issuers (both domestic and foreign) with listed securities in the United States have now had an opportunity to address expanded US sanctions targeting Iran and the new Iran-related disclosure requirements passed into law pursuant to ITRA Sections 218 and 219, respectively. ITRA Section 218 expanded US sanctions targeting Iran to apply to non-US entities owned or controlled by US persons, in addition to US persons. The new federal securities disclosure obligations in ITRA Section 219 and new Section 13(r) of the Securities Exchange Act of 1934 require issuers to publicly disclose certain information relating to a broad range of transactions and dealings related to Iran and certain types of Specially Designated Nationals.
In the first round of required disclosures pursuant to ITRA Section 219 and Section 13(r), issuers have taken a variety of approaches to these requirements and have disclosed a broad range of activities, some of which may have implications for those issuers’ international trade compliance policies. From these initial disclosures, we can already draw some lessons about how ITRA Section 219 is affecting issuers.
Please join us for this informative session.
We look forward to your participation!